The ROE as of November 2024 (TTM) for Ocuphire Pharma, Inc. (OCUP) is -30.19%

According to Ocuphire Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -30.19%. This represents a change of 264.99% compared to the average of -8.27% of the last 4 quarters.

Ocuphire Pharma, Inc. (OCUP) Historical ROE (quarterly & annually)

How has OCUP ROE performed in the past?

The mean historical ROE of Ocuphire Pharma, Inc. over the last ten years is -39.04%. The current -30.19% ROE has changed -22.67% with respect to the historical average. Over the past ten years (40 quarters), OCUP's ROE was at its highest in in the December 2020 quarter at 138.71%. The ROE was at its lowest in in the March 2017 quarter at -1913.27%.

Ocuphire Pharma, Inc. (OCUP) ROE by Quarter and Year

Discovering the peaks and valleys of Ocuphire Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ocuphire Pharma, Inc. (OCUP) Average ROE

How has OCUP ROE performed in the past?

The current ROE of Ocuphire Pharma, Inc. (OCUP) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Ocuphire Pharma, Inc. (OCUP) ROE vs. Peers

How is OCUP’s ROE compared to its peers?

Ocuphire Pharma, Inc.’s ROE is less than Reviva Pharmaceuticals Holdings, Inc. (664.92%), greater than Protalix BioTherapeutics, Inc. (-45.15%), greater than EyePoint Pharmaceuticals, Inc. (-43.24%), greater than SELLAS Life Sciences Group, Inc. (-17349.62%), less than Reviva Pharmaceuticals Holdings, Inc. (664.92%), greater than Eyenovia, Inc. (-615.55%), greater than Cognition Therapeutics, Inc. (-118.11%), greater than TransCode Therapeutics, Inc. (-597.47%), greater than Kodiak Sciences Inc. (-77.23%), less than Checkpoint Therapeutics, Inc. (0%), less than Mustang Bio, Inc. (292.43%), less than Fortress Biotech, Inc. (1.40%), greater than Rigel Pharmaceuticals, Inc. (-226.63%), less than Fortress Biotech, Inc. (46.64%), greater than CTI BioPharma Corp. (-226.63%), less than null (180.42%),

Build a custom stock screener for Ocuphire Pharma, Inc. (OCUP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ocuphire Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ocuphire Pharma, Inc. (OCUP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ocuphire Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.